Leap Therapeutics Inc (LPTX) — Cash Flow Reinvestment Rate
Latest as of June 2016:
0.01x
Leap Therapeutics Inc (LPTX) has a Cash Flow Reinvestment Rate of 0.01x as of June 2016, reinvesting $30.00K (capex $30.00K ) from operating cash flow of $2.08 Million. Check Leap Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$30.00K
Capex + Investments
Operating Cash Flow
$2.08 Million
USD
Capital Expenditures
$30.00K
USD
Annual Cash Flow Reinvestment Rate for Leap Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Leap Therapeutics Inc. For live market cap and broader valuation context, see Leap Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow